×
Back to Agenda
Phased Reviews
Learning Objective : Following significant discussion in recent years, the EU will now consider dynamic regulatory assessment (DRA)/ phased review when the updated General Pharmaceutical Legislation is implemented. This session will explore concrete steps to take for its successful implementation.
Speaker(s)
Agnes Dangy-Caye, DRSC
Regulatory Science & Policy Manager, Sanofi, France
Preparing for Phased Reviews - Laying the Groundwork to Maximize Benefit for Patients
Iain Todd
Senior Manager - Regulatory Intelligence, Regeneron, United Kingdom
Preparing for Phased Reviews - Laying the Groundwork to Maximize Benefit for Patients
Have an account?